As the number of terms used in nomenclature of marketing activities increases, Chris Stevenson questions whether it’s time we standardised.
“That which we call a rose, by any other name would smell as sweet”. We may all agree with Juliet that her lover Romeo would…
Read the full articlepharmaphorum celebrates its first birthday!27th August 2010 | 6 comments
As pharmaphorum celebrates its first birthday, Paul Tunnah reflects on a year of running a pharma social media site and looks forward to the future. Well, I can scarcely believe it myself, but pharmaphorum has reached its first birthday! The last year has certainly flown by, but… | What Are IDEAs Made Of: Efficacy25th August 2010 | 1 comment
The term efficacy is used increasingly in the pharma industry. Mike Rea questions whether the term is used as a banner for anything that fits the bill. Here’s the thing about Efficacy. It doesn’t exist. It is an abstract concept, a shorthand, a broad clustering of things that… |
Looking beyond pharma for portfolio optimisation23rd August 2010 | 1 comment
Trevor Brown outlines an exciting new project where pharma is looking to learn from other industries about how to improve portfolio management and optimisation. Within an increasingly challenging environment, there is significant debate in the pharmaceutical industry directed at… | Engaging OLs ‘over time’ online for greater insight19th August 2010 | 5 comments
In a time-pressured, geographically-vast industry, Neil A. Jones discusses what should be considered to ensure effective online engagement with Opinion Leaders. Despite all the promises of the web to engage opinion leaders and other key stakeholders online for… |
